Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02872311 · ClinicalTrials.gov registry record · NA
Open-Label Influenza Vaccine Evaluation
A NA study of Immune Response, sponsored by Marshfield Clinic Research Foundation.
- Completed
- Registry status
- NA
- Development phase
- 179
- Enrollment target
- 1
- Study location
NCT02872311 is a NA study of Immune Response that has completed, run by Marshfield Clinic Research Foundation. The registered enrollment target is 179 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02872311, a NA study of Immune Response, has completed, sponsored by Marshfield Clinic Research Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 179 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an open-label, randomized trial in up to 210 adults aged 65-74 years to evaluate the immune response to consecutive influenza vaccination across 2 seasons. Participants will be randomized to receive 1 of 3 licensed and recommended vaccines in the first year; 2 arms will receive the same vaccination in the second year and the third arm will be randomized again to 1 of 3 licensed vaccines. All participants will have pre and post-vaccination serum blood draws for a total of 6 draws over 18 months.
Conditions Studied
Interventions
- BIOLOGICAL High Dose Influenza vaccine
- BIOLOGICAL Adjuvanted Influenza vaccine
- BIOLOGICAL Standard Dose Influenza vaccine
- BIOLOGICAL Recombinant Influenza vaccine
Study Locations (1)
Wisconsin
- Marshfield Clinic - Marshfield Center - Marshfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02872311
The ClinicalTrials.gov registry entry for NCT02872311 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 179 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Marshfield Clinic Research Foundation, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Immune Response appearing as the primary indexed condition, and to 4 interventions - of which High Dose Influenza vaccine is the first listed.
NCT02872311 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT02872311 about?
NCT02872311 is a clinical study titled "Open-Label Influenza Vaccine Evaluation". This is an open-label, randomized trial in up to 210 adults aged 65-74 years to evaluate the immune response to consecutive influenza vaccination across 2 seasons. Participants will be randomized to receive 1 of 3 licensed and recommended vaccines in the first year; 2 arms will receive the same vacc...
What is the current status of trial NCT02872311?
This trial is currently completed. It is a NA study. The enrollment target is 179 participants. The study started on 2016-09. Estimated completion is 2018-09.
What conditions does trial NCT02872311 study?
This clinical trial studies the following conditions: Immune Response.
What interventions are being tested in trial NCT02872311?
The interventions under investigation include: High Dose Influenza vaccine (BIOLOGICAL), Adjuvanted Influenza vaccine (BIOLOGICAL), Standard Dose Influenza vaccine (BIOLOGICAL), Recombinant Influenza vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT02872311?
This trial is sponsored by Marshfield Clinic Research Foundation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02872311 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Immune Response
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.